ArticleNaunyn-Schmiedeberg's archives of pharmacology2024

Alleviation of pulmonary fibrosis by the dual PPAR agonist saroglitazar and breast milk mesenchymal stem cells via modulating TGFß/SMAD pathway.

Seba Hassan Attia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.